Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
Mirum has acquired Travere’s rights and assets related to Cholbam® and Chenodal® Travere received $210…
Mirum has acquired Travere’s rights and assets related to Cholbam® and Chenodal® Travere received $210…
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive…
Iteris’ proprietary mobility data and mobility intelligence software to provide critical transportation analytics and speeding…
ATLANTA–(BUSINESS WIRE)–#demanddriventechnologies–Demand Driven Technologies, an emerging leader in supply chain management solutions, is thrilled to…
The new framework for solving the energy efficiency problem outperforms state-of-the-art systems Simultaneous wireless information…
Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by…
EsoCap’s novel targeted delivery platform is designed to increase mucosal contact time and drug deposition…
Fermyon Serverless AI Efficiently Timeshares Each GPU for Thousands of AI Developers Concurrently Fermyon Serverless…
SINGAPORE, Sep 5, 2023 – (ACN Newswire) – Spikes Asia, APAC’s most prestigious and sought-after…
AMSTERDAM, Sep 5, 2023 – (ACN Newswire) – FeedbackFruits, an education technology company that provides…
HONG KONG, Sep 5, 2023 – (ACN Newswire) – As part of the second largest…
NEW YORK & OSLO, Norway & LUXEMBOURG–(BUSINESS WIRE)–FREYR Battery (NYSE: FREY) (“FREYR”), a developer of…
INDRC Pioneers Combination of Biological Sciences and Medicine with Big Data and Artificial Intelligence Approaches…
Latest Round was Led by Portage, a Global FinTech and Financial Services Investment Platform, and…
BERKELEY, Calif. and MAINZ, Germany, Sept. 05, 2023 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ)…
Acquisition of Bioinduction transforms Amber into an integrated developer and manufacturer of intelligent, closed-loop neuromodulation…
Multi-center trial of novel autologous cell therapy APN401 leveraging two GMP-compliant manufacturing sites has received…
Ad hoc announcement pursuant to Art. 53 LR Supplement published by Sandoz ahead of Novartis…
Cohort 1 is completed, and Cohort 2 is 80% recruited Ad Hoc Announcement Pursuant to…
HONG KONG, Sep 5, 2023 – (ACN Newswire) – Jilin Province Chuncheng Heating Company Limited…